CDKN2A and esophageal adenocarcinoma: Point mutations in Barrett esophagus and esophageal adenocarcinoma are relatively uncommon, but 9p loh and promoter hypermethylation appear to be frequent mechanisms of CDKN2A inactivation 117,118.